Literature DB >> 7576179

Identification of a silencer, enhancer, and basal promoter region in the human CD95 (Fas/APO-1) gene.

F Rudert1, E Visser, L Forbes, E Lindridge, Y Wang, J Watson.   

Abstract

Genomic clones for the human CD95 (Fas/APO-1) and CD40 genes have been isolated and 2.3 kb of the CD95 and 0.8 kb of the CD40 gene 5'-flanking regions sequenced. Comparisons of the human CD95 gene with the human CD40 and the murine CD40 and TNFR-II genes showed a low degree of sequence similarity. However, dot matrix analyses revealed conservation of two stretches between human CD95 (-387 to -362 and -288 to 261 in CD95) and murine TNFR-II genes. Additionally, TCCTCC motifs are present within 400 bp up-stream of the ATG of all genes examined. Repeated interferon-beta (IFN-beta) silencer B motifs and a lysozyme silencer 1 motif have been found in the CD95 gene at approximately -1,600 and -1,100, respectively. Sequence comparison of the 5'-flanking regions of the murine and human CD40 genes revealed the presence of a conserved AP-4 site and two SP-1 sites. CD95, CD40, and TNFR-II genes all lack classical TATA and CAAT boxes. However, a strongly increased frequency of CpG dinucleotides was found. Primer extension analysis revealed multiple transcriptional start sites in the CD95 gene, where the usage of individual start sites appeared to be cell type-specific. Functional analysis, using reporter constructs and transient transfections, identified a silencer activity residing between nucleotide positions -1,781 and -1007 and a strong enhancer region between -1,007 and -425 in the human CD95 gene. The region between -425 and -1 retained a basal promoter activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576179     DOI: 10.1089/dna.1995.14.931

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  9 in total

1.  Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients.

Authors:  Milena Nasi; Marcello Pinti; Roberto Bugarini; Leonarda Troiano; Enrico Lugli; Cristian Bellodi; Cristina Mussini; Vanni Borghi; Tommaso Trenti; Fiorella Balli; Roberto Esposito; Andrea Cossarizza
Journal:  Immunogenetics       Date:  2005-10-18       Impact factor: 2.846

2.  Transcription regulator Yin-yang 1: from silence to cancer.

Authors:  Weidong Zhu; Samuel Y Olson; Hermes Garbán
Journal:  Crit Rev Oncog       Date:  2011

3.  Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas.

Authors:  J Peli; M Schröter; C Rudaz; M Hahne; C Meyer; E Reichmann; J Tschopp
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

4.  APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Richa Singh; Vandana Pradhan; Manisha Patwardhan; K Ghosh
Journal:  Indian J Hum Genet       Date:  2009-09

Review 5.  Regulation of apoptosis-related genes by nitric oxide in cancer.

Authors:  Samuel Y Olson; Hermes J Garbán
Journal:  Nitric Oxide       Date:  2008-06-02       Impact factor: 4.427

6.  Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma.

Authors:  L M Butler; A Dobrovic; T Bianco; P A Cowled
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

7.  Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.

Authors:  Ying Chen; Hanfei Wang; Yunwen Yan; Min Ren; Cunye Yan; Benzhong Wang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

8.  p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.

Authors:  M Müller; S Wilder; D Bannasch; D Israeli; K Lehlbach; M Li-Weber; S L Friedman; P R Galle; W Stremmel; M Oren; P H Krammer
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

9.  FAS and FASL gene polymorphisms are not associated with hepatitis B virus infection based on a case-control study in a Brazilian population.

Authors:  Bárbara B Santana; Maria Luana C Viégas; Simone R S S Conde; Marluísa O G Ishak; Ricardo Ishak; Antonio C R Vallinoto
Journal:  Dis Markers       Date:  2013-11-17       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.